Google
×
Oct 12, 2022 · Here, we evaluated outcomes of 547 patients (CNS-positive = 96, CNS-negative = 451) who were allografted in the first complete remission (CR1) ...
Outcomes of allogeneic hematopoietic cell transplantation (allo-HCT) for adult acute lymphoblastic leukemia (ALL) have improved over time. Studies have shown ...
People also ask
May 10, 2023 · Our results suggest that ALL patients with isolated FCM-positive CNS involvement are at a higher risk of recurrence after transplantation.
CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete Remission ; Hemasphere · 6 · 11.
Mar 7, 2024 · A study on 2,045 patients reports the incidence of CNS relapse after allo-HSCT for acute myeloid leukemia (AML) to be 1.81%. Pre-allo-HSCT CNS ...
Missing: HCT | Show results with:HCT
Here, we evaluated outcomes of 547 patients (CNS-positive = 96, CNS-negative = 451) who were allografted in the first complete remission (CR1) between 2009 and ...
Nearly two-third patients had CNS involvement at the initial diagnosis of leukemia. Complete remission of CNS leukemia was attained in 58 (88%) patients, and ...
The risk for CNS disease and/or recurrence, along with approaches to treatment and prophy- laxis at the time of diagnosis, have been described primarily for.
Here, we evaluated outcomes of 547 patients (CNS-positive = 96, CNS-negative = 451) who were allografted in the first complete remission (CR1) between 2009 and ...
Here, we evaluated outcomes of 547 patients (CNS-positive = 96, CNS-negative = 451) who were allografted in the first complete remission (CR1) between 2009 and ...